Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Distinct mutation profiles between primary bladder cancer and circulating tumor cells warrant the use of circulating tumors cells as cellular resource for mutation follow-up

Fig. 2

Mutation abundance of primary tumors and CTC (circulating tumor cells) genomes. (a) Mutation abundance of primary tumors and their matched CTC genomes for 20 cases of UBC. (b) Relative proportion of common mutations (i.e., those commonly observed both for primary and CTC genomes) and region-specific mutations in given cases

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us